Skip to Content

Cardiothoracic Research

At Queen's

Our Research

Queen's University Belfast has established itself as a leading institution in the field of vascular research, contributing significantly to advancements in medical knowledge and patient care. The university's commitment to innovative research is exemplified by the Wellcome-Wolfson Institute for Experimental Medicine, a globally recognised centre of excellence. The institute has garnered international acclaim for its groundbreaking studies focusing on Diabetic Vascular Disease.

Queen's also specialises in thoracic oncology research, involving a multidisciplinary approach which encompasses early detection, personalised treatment strategies, and understanding the underlying molecular mechanisms driving cancer progression. 

Researchers at Queen's employ cutting-edge technologies including genomic analysis, imaging modalities, and immunotherapy to decipher the complexities of thoracic cancers. Through collaborative efforts between clinicians, scientists, and industry partners, Queen's aims to improve patient outcomes by developing innovative therapies, biomarkers for early diagnosis, and advancing our understanding of tumour biology, ultimately striving towards more effective treatments and better quality of life for patients.

Research topics